We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.08%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$27.3B
AUM Growth
-$28.2B
(-51%)
Cap. Flow
-$28.9B
Cap. Flow
% of AUM
-105.88%
Top 10 Holdings %
Top 10 Hldgs %
23.06%
Holding
1,354
New
88
Increased
57
Reduced
1,096
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$36.3M |
| 2 |
Paycom
PAYC
|
+$30.3M |
| 3 |
Airbnb
ABNB
|
+$26.2M |
| 4 |
Charles River Laboratories
CRL
|
+$22.6M |
| 5 |
Bio-Techne
TECH
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Amazon
AMZN
|
+$1.15B |
| 3 |
Apple
AAPL
|
+$1.01B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$881M |
| 5 |
Comcast
CMCSA
|
+$482M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.21% |
| 2 | Healthcare | 16.15% |
| 3 | Financials | 15.41% |
| 4 | Consumer Discretionary | 12.5% |
| 5 | Communication Services | 11.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Booking.com
BKNG
$158B
| $187M | 0.69% |
1,971,900
-1,701,550
| -46% | -$153M |
|
27
Procter & Gamble
PG
$338B
| $186M | 0.68% |
1,328,049
-1,421,313
| -52% | -$201M |
|
28
Mondelez International
MDLZ
$83.4B
| $184M | 0.68% |
3,168,134
-3,522,924
| -53% | -$219M |
|
29
Danaher
DHR
$139B
| $183M | 0.67% |
678,755
-742,823
| -52% | -$202M |
|
30
S&P Global
SPGI
$125B
| $171M | 0.63% |
403,203
-347,813
| -46% | -$151M |
|
31
Intel
INTC
$434B
| $166M | 0.61% |
3,116,922
-5,367,446
| -63% | -$291M |
|
32
Advanced Micro Devices
AMD
$729B
| $163M | 0.6% |
1,581,721
-1,513,981
| -49% | -$155M |
|
33
Bristol-Myers Squibb
BMY
$130B
| $161M | 0.59% |
2,715,834
-2,373,872
| -47% | -$156M |
|
34
Align Technology
ALGN
$13B
| $160M | 0.59% |
240,818
-168,860
| -41% | -$115M |
|
35
Estee Lauder
EL
$30.9B
| $157M | 0.57% |
522,094
-449,994
| -46% | -$147M |
|
36
Elevance Health
ELV
$82.2B
| $156M | 0.57% |
417,968
-377,862
| -47% | -$144M |
|
37
McDonald's
MCD
$193B
| $153M | 0.56% |
634,632
-619,594
| -49% | -$148M |
|
38
Home Depot
HD
$340B
| $151M | 0.55% |
460,244
-572,628
| -55% | -$188M |
|
39
Nike
NKE
$64.2B
| $148M | 0.54% |
1,015,636
-1,007,962
| -50% | -$164M |
|
|
SCHW
40
Charles Schwab
SCHW
$184B
| $141M | 0.52% |
1,929,588
-1,656,252
| -46% | -$118M |
|
41
Edwards Lifesciences
EW
$49.3B
| $140M | 0.51% |
1,235,590
-1,060,220
| -46% | -$121M |
|
42
Accenture
ACN
$107B
| $137M | 0.5% |
428,223
-35,241
| -8% | -$11.5M |
|
43
Zoetis
ZTS
$32.5B
| $135M | 0.5% |
724,321
-531,701
| -42% | -$107M |
|
44
Agilent Technologies
A
$39.6B
| $134M | 0.49% |
853,800
-513,102
| -38% | -$83M |
|
45
Intuit
INTU
$91.9B
| $134M | 0.49% |
247,891
-262,309
| -51% | -$141M |
|
46
Broadcom
AVGO
$1.82T
| $134M | 0.49% |
2,755,740
-2,250,360
| -45% | -$109M |
|
47
Berkshire Hathaway Class B
BRK.B
$1.1T
| $130M | 0.48% |
474,668
-473,694
| -50% | -$133M |
|
48
NXP Semiconductors
NXPI
$63B
| $129M | 0.47% |
659,442
-637,020
| -49% | -$132M |
|
49
Eli Lilly
LLY
$1.09T
| $129M | 0.47% |
558,785
-450,693
| -45% | -$111M |
|
50
eBay
EBAY
$51.7B
| $124M | 0.45% |
1,778,175
-2,354,469
| -57% | -$169M |
|
Similar funds
HF
KBC Group's Q3 2021 Portfolio in Review
As of Q3 2021, KBC Group held 1,354 positions worth $27.3B, down 51% from $55.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
KBC Group withdrew a net $28.9B in Q3 2021, closing 66 positions and reducing 1,096 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $42.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, KBC Group opened a new position in DoorDash worth $9.43M.
- KBC Group's largest Q3 2021 buy was DoorDash: 45,764 shares worth $9.43M.
- KBC Group added most to Zscaler in Q3 2021, an estimated $36.3M increase.
- KBC Group's biggest Q3 2021 reduction was Microsoft, cutting an estimated $1.57B.
- KBC Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $42.6M.
- KBC Group's ten largest holdings make up 23% of its $27.3B portfolio in Q3 2021.
- KBC Group opened 88 new positions and closed 66 in Q3 2021.
- KBC Group's portfolio value fell 51% quarter-over-quarter to $27.3B.
Based on KBC Group's 13F filing for Q3 2021, filed 10 Nov 2021.